GLP-1s for Weight Loss: What the Evidence Actually Says

The honest answer to 'how much weight will I lose?' is: it depends on the drug, the dose, how long you're on it, and how you respond. But the randomized trials give us a much better range than the hype or the fear-mongering.

How much weight do people lose on GLP-1s?

In the pivotal weight-loss trials, people on semaglutide (Wegovy®) lost roughly 15% of body weight at 68 weeks, and those on tirzepatide (Zepbound®) lost roughly 20–22% at 72 weeks — both far above placebo. Those are trial averages, not promises, and trial participants were closely monitored.

Who responds best to GLP-1s?

• People with a higher starting BMI generally lose more in absolute terms.
• Response is dose-dependent — higher approved doses produce more loss.
• A meaningful minority respond less than average; a small number don't respond at all.
• Lifestyle factors (protein, activity, sleep) measurably change the outcome.

What happens when you stop taking a GLP-1?

This is the part most marketing leaves out. In the extension trials, people who switched to placebo after a year on the drug regained most of the weight they'd lost. GLP-1s suppress appetite; when the drug is gone, the appetite returns. That's why 'coming off' is its own discipline — we cover it in detail in the Coming Off GLP-1s guide.

Is the weight you lose on a GLP-1 fat or muscle?

A growing concern in the research is that a substantial share of the weight lost on GLP-1s is lean mass (muscle) — in some analyses up to around a third or more. That's why protein intake and resistance training matter, and it's the subject of our muscle-loss guide.